These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. Levi M; Choi G; Picavet C; Hack CE J Allergy Clin Immunol; 2006 Apr; 117(4):904-8. PubMed ID: 16630950 [TBL] [Abstract][Full Text] [Related]
28. Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States. Bernstein JA; Moellman JJ Postgrad Med; 2012 May; 124(3):91-100. PubMed ID: 22691903 [TBL] [Abstract][Full Text] [Related]
29. Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs. Riedl MA; Craig TJ; Banerji A; Aggarwal K; Best JM; Rosselli J; Hahn R; Radojicic C Allergy Asthma Proc; 2021 May; 42(3):S17-S25. PubMed ID: 33980329 [TBL] [Abstract][Full Text] [Related]
30. An update on hereditary angioedema. Hsu D; Shaker M Curr Opin Pediatr; 2012 Oct; 24(5):638-46. PubMed ID: 22935756 [TBL] [Abstract][Full Text] [Related]
31. Hereditary angioedema: children should be considered for training in self-administration. Abdel-Karim O; Dizdarevic A; Bygum A Pediatr Dermatol; 2014; 31(6):e132-5. PubMed ID: 25208595 [TBL] [Abstract][Full Text] [Related]
32. The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update. Maurer M; Magerl M; Ansotegui I; Aygören-Pürsün E; Betschel S; Bork K; Bowen T; Balle Boysen H; Farkas H; Grumach AS; Hide M; Katelaris C; Lockey R; Longhurst H; Lumry WR; Martinez-Saguer I; Moldovan D; Nast A; Pawankar R; Potter P; Riedl M; Ritchie B; Rosenwasser L; Sánchez-Borges M; Zhi Y; Zuraw B; Craig T Allergy; 2018 Aug; 73(8):1575-1596. PubMed ID: 29318628 [TBL] [Abstract][Full Text] [Related]
33. rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency. Varga L; Farkas H Expert Rev Clin Immunol; 2011 Mar; 7(2):143-53. PubMed ID: 21426252 [TBL] [Abstract][Full Text] [Related]
34. Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate. Martinez-Saguer I; Rusicke E; Aygören-Pürsün E; Heller C; Klingebiel T; Kreuz W Am J Obstet Gynecol; 2010 Aug; 203(2):131.e1-7. PubMed ID: 20471627 [TBL] [Abstract][Full Text] [Related]
35. Management of hereditary angioedema. Dempster J Nurs Stand; 2013 May 15-21; 27(37):35-40. PubMed ID: 23914693 [TBL] [Abstract][Full Text] [Related]
36. Hereditary angioedema: current and emerging treatment options. Levy JH; Freiberger DJ; Roback J Anesth Analg; 2010 May; 110(5):1271-80. PubMed ID: 20418292 [TBL] [Abstract][Full Text] [Related]
37. Current medical management of hereditary angioedema: results from a large survey of US physicians. Riedl M; Gower RG; Chrvala CA Ann Allergy Asthma Immunol; 2011 Apr; 106(4):316-322.e4. PubMed ID: 21457880 [TBL] [Abstract][Full Text] [Related]
38. Successful management of hereditary angioedema during tonsillectomy: a case report. Hermans C; Vander Vorst S; Lambert C Blood Coagul Fibrinolysis; 2012 Mar; 23(2):155-7. PubMed ID: 22193715 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study. Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164 [TBL] [Abstract][Full Text] [Related]